2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Single-Center Initial Experience in Treating Chronic Hepatitis C in Kidney Transplant Recipients.

G. Meinerz, C. da Silva, R. Bruno, E. Keitel, V. Garcia.
Single-Center, Prospective, Open Label Pilot Study to Investigate the Effectiveness of Everolimus Associated with Mycophenolic Acid and Prednisone in Adult Patients Submitted to an Allograft Renal Transplant with Calcineurin Inhibitor Withdrawl on Week 16th.

L. Giordano,^1,2 M. Lasmar,^1,2 H. Vianna,^1,2 E. Lasmar.^1,2
Sirolimus Prolonged Survival After Living Donor Liver Transplantation for HCC Beynd Milan Criteria; Outcome of a Multicenter Prospective Randomized Phase II Trial (ClinicalTrials.gov Identifier: NCT01374750).

K.-W. Lee,¹ S.-H. Kim,² N.-J. Yi,¹ S.-K. Hong,¹ G. Yoon,¹ H. Kim,¹ D. Oh,¹ S.-S. Han,² S.-J. Park,² K.-S. Suh.¹
SIRPα⁺ DCs and the Time-Dependent CD4⁺CD8⁺ Double Positive T Cell Infiltration in Accepted Renal Allografts.

T. Ashry,^1,2 C. Yang,² B. Jiang,² D. Ndishabandi,² P. Russel,^1,2 R. Colvin,^1,2 J. Madsen,^1,2 A. Alessandrini.^1,2
Small Pediatric Donor Kidney Transplantation in Pediatric Recipients.

H. Yaffe,^1,2 P. Friedmann,² L. Kayler.³
Socioeconomic Status and Perceived Donation-Related Financial Burden Among Living Kidney Donors.

J. Ruck, A. Massie, M. Henderson, D. Segev.
Solid Organ Cancer After Kidney Transplantation: Risk Factors and Long Term Impact.

A. Buxeda, D. Redondo, M. Pérez-Sáez, A. Bartolomé, M. Mir, A. Pascual, A. Sans, M. Crespo, J. Pascual.
Soluble Fibrinogen-Like Protein 2 Regulates Differentiation and Enhances Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Allograft Immunity.

C. Yang, B. Peng, M. Xu, T. Zhu.
Soluble Human Leukocyte Antigen-G Levels and Prolonged Allograft Survival: A Demographic Analysis.

C. Callaway,¹ A. Ajith,² V. Portik-Dobos,² P. Best,³ C. Zayas,³ R. Kapoor,³ A. Horuzsko,² L. Mulloy.³
Specific Gene Expression Signature of Complement-Activating Donor Specific Anti-HLA Antibody-Mediated Rejection in Kidney Allografts.

C. Lefaucheur,¹ D. Viglietti,¹ L. Hidalgo,² O. Aubert,¹ A. Zeevi,³ P. Halloran,² A. Loupy.¹

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z